Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

AMD Faces Critical Pricing Decision as Memory Costs Soar

Robert Sasse by Robert Sasse
November 18, 2025
in AI & Quantum Computing, Gaming & Metaverse, Semiconductors, Tech & Software
0
AMD Stock
0
SHARES
104
VIEWS
Share on FacebookShare on Twitter

Advanced Micro Devices (AMD) finds itself navigating a complex pricing dilemma that could significantly impact its market position. The semiconductor leader is reportedly preparing to implement substantial price increases for its graphics processing units (GPUs), creating potential headwinds in a market where both AI developers and PC gamers depend on affordable hardware. Investors responded immediately to the news, sending shares down 0.79% during Monday’s trading session. This development raises crucial questions about AMD’s strategic positioning and whether these pricing adjustments might undermine the company’s impressive growth trajectory.

Supply Chain Pressures Drive Pricing Strategy

The root cause of AMD’s planned price adjustments lies deep within the supply chain. Manufacturers of DRAM and NAND flash memory are struggling to keep pace with production demands, particularly as the artificial intelligence sector generates unprecedented requirements for memory components. This supply-demand imbalance has triggered dramatic cost increases throughout the memory market.

AMD now appears positioned to pass these additional expenses along to its partners. Market observers express concern that elevated GPU prices could dampen consumer demand, especially within the price-sensitive gaming segment. However, AMD’s processors remain essential components for AI data center operations—a business segment generally considered less vulnerable to price fluctuations.

Strong Annual Performance Despite Recent Setback

Despite the single-day decline, AMD shares remain among the standout performers in the semiconductor sector for 2025, having advanced more than 102% since the beginning of the year. This remarkable performance primarily stems from overwhelming demand for AMD components powering AI data centers, which generated third-quarter revenue of $9.25 billion—exceeding market expectations.

Should investors sell immediately? Or is it worth buying AMD?

The company’s growth narrative extends well beyond artificial intelligence. AMD’s client segment, encompassing desktop and laptop processors, delivered record CPU revenues that surprised analysts, while the gaming division also demonstrated solid growth. Average selling prices within the client business surged 42% year-over-year, indicating that AMD maintains significant pricing power independent of the AI boom.

Analyst Community Maintains Confidence

Financial analysts appear unfazed by the near-term stock weakness. TD Cowen analyst Joshua Buchalter reaffirmed his Outperform rating with a $290 price target, suggesting substantial upside potential. The broader Wall Street consensus maintains a “Moderate Buy” recommendation, with average price targets sitting approximately 15% above current trading levels.

AMD’s executive leadership projects confidence in their strategic direction. The company targets revenue growth exceeding 35% annually over the next three to five years. The GPU price increases may represent a calculated risk—as long as AI demand continues its explosive growth trajectory, AMD likely maintains sufficient leverage to pass along higher costs without sacrificing market share.

Ad

AMD Stock: Buy or Sell?! New AMD Analysis from March 25 delivers the answer:

The latest AMD figures speak for themselves: Urgent action needed for AMD investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

AMD: Buy or sell? Read more here...

Tags: AMD
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Take-Two Stock
Earnings

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
IBM Stock
Analysis

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Rocket Lab USA Stock
Analysis

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

March 25, 2026
Next Post
Asml Stock

ASML's Strategic Moves Signal Confidence Amid Political Tensions

Lynas Stock

Rare Earths Rally Fuels Lynas Stock Surge

Omv Stock

OMV Shares Face Analyst Downgrade Amid Sector Challenges

Recommended

BigBearai Holdings Stock

BigBear.ai Faces Critical Test as Revenue Plummets and Losses Mount

6 months ago
D-Wave Quantum Stock

D-Wave Quantum: CFO’s Multi-Million Dollar Exit Amidst Major Capital Raise

4 months ago
Brightcove Stock

Bending Spoons Forges AI-Powered Streaming Future with Brightcove at the Core

6 months ago
Microsoft Stock

Microsoft Faces Critical Earnings Test Amid AI Expectations

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

Trending

Bionxt Solutions Stock
Healthcare

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

by SiterGedge
March 25, 2026
0

BioNxt Solutions has formally initiated the commercial phase for its sublingual drug delivery platform, marking a significant...

Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon
  • Ocugen Shares Slide Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com